ESC 365 - The importance of type of antithrombotic treatment after aortic valve replacement for the risk of future thromboembolic and bleeding events in aortic stenosis - Comparison of mechanical -, bio prosthetic and trans-catheter (TAVI) aortic valve replacement.

ESC Premium Access

The importance of type of antithrombotic treatment after aortic valve replacement for the risk of future thromboembolic and bleeding events in aortic stenosis - Comparison of mechanical -, bio prosthetic and trans-catheter (TAVI) aortic valve replacement.

Session: ESC Grants for Medical Research Innovation

Topic: Aortic valve disease

Speaker: Associate Professor C. Christersson (Uppsala, SE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Associate Professor Christina Christersson

Uppsala University, Uppsala (Sweden)

5 presentations

1 follower

4 more presentations in this session

Modeling the Individual Risk of Thrombosis in Oncology (MIRTO).

Speaker: Doctor J. Soria Fernandez (Sant Pau, ES)

Dual approach cardiac MRI for molecular assessment and interventional treatment of vulnerable coronary plaques in a porcine model.

Speaker: Professor T. Heidt (Buhl, DE)

Systemic versus site targeted treatment of neoatherosclerosis.

Speaker: Doctor M. Joner (Munich, DE)

Identification of mirRNA profiles associated with venous thromboembolism and recurrent events (IMPROVEMENTS).

Speaker: Doctor D. Tregouet (Paris, FR)

Access the full session

ESC Grants for Medical Research Innovation

Speakers: Associate Professor C. Christersson, Doctor J. Soria Fernandez, Professor T. Heidt, Doctor M. Joner, Doctor D. Tregouet

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources